DiviDrip · TSHA

TSHA — Taysha Gene Therapies, Inc.

TSHA is Taysha Gene Therapies, Inc. (Healthcare) — a non-dividend-paying stock. Trading at $5.57. Market cap: $1.84B. Capital Quality Rank: 74/100 — Elite compounder.

Stock snapshot

Price$5.57
Market cap$1.84B
SectorHealthcare
ExchangeNMS
Pays dividendNo

Capital Quality & fundamentals

DiviDrip's Capital Analytics engine ranks every non-dividend stock 1-100 on a 4-factor composite (Shareholder Yield 30%, Cash-Flow ROI 25%, Operating Momentum 25%, Tail-Risk 20%) — sector-neutralized so a biotech isn't penalized for negative earnings the way a utility would be.

Capital Quality Rank (1-100)74 / 100 · Elite compounder
Revenue CAGR (3y)57.5%
Shareholder buyback yield-21.76%
Altman Z-score zoneSafe

About TSHA

Taysha Gene Therapies Inc is a clinical-stage biotechnology company focused on advancing AAV-based gene therapies for the treatment of severe monogenic diseases of the central nervous system, or CNS. The company's clinical program TSHA-102 is in development for the treatment of Rett syndrome, a rare neurodevelopmental disorder with no approved disease-modifying therapies that address the genetic root cause of the disease. The Company views its operations and manages its business as a single operating segment, the gene therapy segment, which is the business of developing AAV-based gene therapies for the treatment of rare monogenic diseases of the central nervous system.

Listed2020Employees99HQDallas, TXSectorHealthcareWebsitetayshagtx.com

Related non-dividend companies

Other non-dividend stocks investors research alongside TSHA. Peer set from Massive news + returns similarity, filtered to names we currently track.

Frequently asked

What is TSHA's current stock price?

TSHA (Taysha Gene Therapies, Inc.) is currently trading at $5.57.

Does TSHA pay a dividend?

TSHA (Taysha Gene Therapies, Inc.) does not currently pay a regular dividend.

What is TSHA's Capital Quality Rank?

TSHA has a Capital Quality Rank of 74/100 — Elite compounder. This score blends ROIC, revenue growth, buybacks, and balance-sheet health.

Track TSHA in DiviDrip

Add TSHA to your watchlist on DiviDrip to monitor price, fundamentals, and Capital Quality Rank week-over-week. Built for long-term investors tracking both dividend and non-dividend names.

Data refreshed 2026-09-04. Not investment advice. Prices change continuously; always verify the latest numbers in the live app before buying.

Related guides

DiviDrip is a free dividend portfolio tracker built by dividend investors, for dividend investors. Try it free — no payment, no upsell, ever. Read the How-To to see how each tool fits together, or browse the Glossary for every term defined plain-English.

Disclaimer: The information provided on this website/service is for informational purposes only and does not constitute financial, investment, or legal advice. Investing in stocks involves high risk, including the loss of principal. We are not responsible for any financial losses or damages resulting from your reliance on this data. Always consult with a qualified financial professional before making investment decisions.

Trademark Notice: Twylight Crow's Dividend Tracker (formerly indexed as DiviDrip) is an independent portfolio utility. This tool is not affiliated with, authorized, endorsed by, or in any way officially connected to Dividrip.com or its international affiliates.

Contact: dividrip@twylightcrow.com© 2026 Twylight Crow